1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid
C19H17F3N6O2 — CID 167902395
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid
1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid (PubChem CID 167902395) has the molecular formula C19H17F3N6O2 and a molecular weight of 418.38 g/mol. Its IUPAC name is 1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 167902395 |
| Molecular Formula | C19H17F3N6O2 |
| Molecular Weight | 418.38 g/mol |
| Exact Mass | 418.14 |
| IUPAC Name | 1-(2H-benzotriazol-5-yl)-N-[(1-phenylpyrazol-4-yl)methyl]methanamine;2,2,2-trifluoroacetic acid |
| SMILES | O=C(O)C(F)(F)F.c1ccc(-n2cc(CNCc3ccc4n[nH]nc4c3)cn2)cc1 |
| InChI | InChI=1S/C17H16N6.C2HF3O2/c1-2-4-15(5-3-1)23-12-14(11-19-23)10-18-9-13-6-7-16-17(8-13)21-22-20-16;3-2(4,5)1(6)7/h1-8,11-12,18H,9-10H2,(H,20,21,22);(H,6,7) |
| InChIKey | MFFKKOHGRRVTAA-UHFFFAOYSA-N |
| XLogP | 3.07 |
| TPSA | 108.72 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.38 |
| LogP ≤ 5 | 3.07 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167902395 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.